Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.855 NOK 0.82% Market Closed
Market Cap: 732.9m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Wall Street
Price Targets

HBC Price Targets Summary
Hofseth Biocare ASA

There are no price targets for HBC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hofseth Biocare ASA Competitors:
Price Targets
ALERS
Eurobio Scientific SA
20% Upside
ASND
Ascendis Pharma A/S
47% Upside
4893
Noile-Immune Biotech Inc
129% Upside
ALNY
Alnylam Pharmaceuticals Inc
30% Upside
MREO
Mereo Biopharma Group PLC
89% Upside
BIOCON
Biocon Ltd
7% Downside
GILD
Gilead Sciences Inc
13% Upside
COYA
Coya Therapeutics Inc
159% Upside

Revenue
Forecast

Revenue Estimate
Hofseth Biocare ASA

For the last 8 years the compound annual growth rate for Hofseth Biocare ASA's revenue is 17%. The projected CAGR for the next 8 years is -5%.

17%
Past Growth
-5%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Hofseth Biocare ASA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Hofseth Biocare ASA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HBC's stock price target?
Not Available

HBC doesn't have any price targets made by Wall Street professionals.

What is Hofseth Biocare ASA's Revenue forecast?
Projected CAGR
-5%

For the last 8 years the compound annual growth rate for Hofseth Biocare ASA's revenue is 17%. The projected CAGR for the next 8 years is -5%.

Back to Top